Last updated: Nov 20, 2026, 12:00 AM

Liminatus Pharma, Inc. Class A Common Stock Exchange (NASDAQ, USD)

LIMN

2.51
-0.02 (-0.67%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
177.57%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
3.99M
Price/Sales
-
Ent value
4.08M
Price/Book
13.27
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open3.13
Daily high3.13
Daily low2.92
Daily Volume32K
All-time high5.16
1y analyst estimate-
Beta0.78
EPS (TTM)-26.36
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Liminatus Pharma, Inc. Class A Common Stock's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
LIMNS&P500
Current price drop from All-time high-51.36%-11.46%
Highest price drop-95.17%-56.47%
Date of highest drop6 Aug 20269 Mar 2009
Avg drop from high-63.01%-10.64%
Avg time to new high29 days12 days
Max time to new high136 days1805 days